A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Journal of Hygiene

• Publication date

  1976-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1017/S002217240002458XPMID 1068195PMCID PMC2129851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A surface antigen influenza vaccine: 2. Pyrogenicity and antigenicity

  1976cited by this paper
• An adsorbed surface-antigen influenza vaccine and its serological activity in volunteers

  1976cited by this paper
• The protection of ferrets against influenza by immunization with a split influenza vaccine.

  1975cited by this paper
• A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters

  1975cited by this paper
• Induction of partial immunity to influenza by a neuraminidase-specific vaccine.

  1974cited by this paper
• Effect of neuraminidase antibody on Hong Kong influenza.

  1973cited by this paper
• Crystalline antigen from the influenza virus envelope.

  1972cited by this paper
• The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses

  1972cited by this paper
• Lunar Electrical Conductivity—Reply

  1972cited by this paper
• A quantitative, single-radial-diffusion test for immunological studies with influenza virus.

  1972cited by this paper
• Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees.

  1971cited by this paper
• Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines

  1971cited by this paper
• Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine.

  1971cited by this paper
• The effect of nonaqueous solvents on the quaternary structure of viruses: a procedure for the simultaneous concentration, purification and disruption of influenza viruses.

  1971cited by this paper
• The characterization of subviral particles derived from influenza virus.

  1971cited by this paper
• Degradation of influenza virus by non-ionic detergent

  1970cited by this paper
• Influenza immunization. A new vaccine.

  1969cited by this paper
• Purification of Influenza Virus in the K-II Zonal Centrifuge

  1969cited by this paper
• Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion.

  1969cited by this paper
• Influenza Immunization: A New Vaccine

  1969cited by this paper
• Purified influenza virus vaccine. A study of viral reactivity and antigenicity.

  1968cited by this paper
• Purified influenza virus vaccine. A study of viral reactivity and antigenicity.

  1968cited by this paper
• Protective Effects of Specific Immunity to Viral Neuraminidase on Influenza Virus Infection of Mice

  1968cited by this paper
• Purification of Large Quantities of Influenza Virus by Density Gradient Centrifugation

  1967influential reference
• Influenza immunization.

  1967cited by this paper
• Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether- and detergent-disrupted virus.

  1966cited by this paper
• COMPARISONS OF SEROLOGIC AND FEBRILE RESPONSES IN HUMANS TO VACCINATION WITH INFLUENZA A VIRUSES OR THEIR HEMAGGLUTININS.

  1964cited by this paper
• The structure and composition of the myxoviruses. II. Components released from the influenza virus particle by ether.

  1961cited by this paper
• A rapid method of total lipid extraction and purification.

  1959cited by this paper
• The thiobarbituric acid assay of sialic acids.

  1959cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• The estimation of phosphorus.

  1940cited by this paper

• Current Status and Challenges of Vaccine Development for Seasonal Human Coronaviruses

  2025cites this paper
• Influenza vaccines: Past, present, and future

  2021cites this paper
• Challenges of Making Effective Influenza Vaccines.

  2020cites this paper
• Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenza.

  2019cites this paper
• Influenza Vaccines—Are They Efficacious or Not?

  2019cites this paper
• Novel Platforms for the Development of a Universal Influenza Vaccine

  2018cites this paper
• Vaccine adjuvant formulations: a pharmaceutical perspective.

  2013cites this paper
• Traditional and New Influenza Vaccines

  2013cites this paper
• Influenza virus surveillance, vaccine strain selection, and manufacture.

  2012cites this paper
• Development and testing of the Australian pandemic influenza vaccine – a timely response

  2011cites this paper
• History and evolution of influenza vaccines.

  2011cites this paper
• Development of New Vaccine－New Method to Prepare Artificial Membrane Vaccine using Inter-Membrane Protein Transfer

  2011cites this paper
• Influenza Vaccines Have a Short but Illustrious History of Dedicated Science Enabling the Rapid Global Production of A/Swine (H1N1) Vaccine in the Current Pandemic

  2010cites this paper
• Quantitative Analysis of Influenza Virus-Specific B Cell Responses Generated by Infection and Vaccination

  2009cites this paper
• Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant.

  2008cites this paper
• Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling

  2008cites this paper
• Vaccines Against Pandemic Influenza: What Can be Done Before the Next Pandemic?

  2008cites this paper
• New vaccine approaches for seasonal and pandemic influenza.

  2008cites this paper
• University of Groningen Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling Geeraedts,

  2008cites this paper
• Influenza vaccines have a short but illustrious history

  2008cites this paper
• Intranasal delivery of whole influenza vaccine prevents subsequent allergen‐induced sensitization and airway hyper‐reactivity in mice

  2007cites this paper
• Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic

  2007cites this paper
• Avian influenza: A pandemic waiting in the wings?

  2006cites this paper
• Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.

  2005cites this paper
• Use of the enzyme-linked immunosorbent assay (ELISA) for the estimation of serum antibodies in an influenza virus vaccine study

  2005cites this paper
• Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine Antigens

  2000cites this paper
• Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines

  1998cites this paper
• Adult immunization for influenza and pneumococcal infections

  1997cites this paper
• Influenza Vaccination in Older Patients

  1995cites this paper
• Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

  1995cites this paper
• Characteristics of Cytotoxic T Lymphocytes Directed to Influenza Virus Haemagglutinin Elicited by Immunization with Muramyldipeptide‐Influenza Liposome Vaccine

  1995cites this paper
• Morphological and biochemical characterization of influenza vaccines commercially available in the United Kingdom.

  1994cites this paper
• Single-radial-immunodiffusion as an in vitro potency assay for human inactivated viral vaccines.

  1993cites this paper
• Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses.

  1990cites this paper
• Antibody response to inactivated influenza vaccines of various antigenic concentrations.

  1990cites this paper
• [High performance liquid chromatography and characterization of structural proteins of the influenza virus].

  1990cites this paper
• The ISCOM: an immunostimulating complex.

  1987cites this paper
• Host antigens associated with haemagglutinin.

  1985cites this paper
• Antibody response and persistence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine

  1985cites this paper
• Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes.

  1985cites this paper
• Quantification of haemagglutinin of influenza Tween-ether split vaccines by immunodiffusion.

  1985cites this paper
• [Preparative method of isolating influenza virus glycoproteins].

  1985cites this paper
• The quantification of the haemagglutinin content of influenza whole virus and Tween-ether split vaccines.

  1983cites this paper
• A comparison of live and inactivated influenza A (H1N1) virus vaccines: Short-term immunity

  1983cites this paper
• Clinical reactions and antibody responses to influenza vaccines. A comparison of split or subunit vaccines in children and young adults.

  1983cites this paper
• A comparison of live and inactivated influenza A (H1N1) virus vaccines

  1983cites this paper
• Towards a subunit influenza vaccine prepared by affinity chromatography on immobilized lectin

  1983cites this paper
• [Glycoproteins of RNA-containing enveloped viruses].

  1983cites this paper
• The estimation of host antigen in experimental and commercial influenza subunit preparations by delayed-type hypersensitivity reaction.

  1983cites this paper
• Development of Vaccines and Immunization Procedures (Influenza Trials Sub-Committee)

  1983cites this paper
• A comparison oflive andinactivated influenza A (HlNl) virus vaccines 2.Long-term immunity Report totheMedical Research Council Committee onthe Development ofVaccines andImmunization Procedures (Influenza Trials Subcommittee)

  1983cites this paper
• A comparative study of the reactogenicity and immunogenicity of two inactivated influenza vaccines in children.

  1982cites this paper
• The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines.

  1982cites this paper
• An enzyme-linked immunosorbent assay (ELISA) for influenza haemagglutinin.

  1982cites this paper
• Reactogenicity and immunogenicity of three inactivated influenza virus vaccines in children.

  1981cites this paper
• Immunogenicity of influenza A/USSR (H1N1) subunit vaccine in unprimed young adults

  1981cites this paper
• Responses of volunteers to inactivated influenza virus vaccines

  1981cites this paper
• Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses

  1981cites this paper
• Characterisation of rubella virus hemagglutinin rosettes

  1981cites this paper
• Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.

  1980cites this paper
• Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents.

  1980cites this paper
• New developments in the measurement of the hemagglutinin content of influenza virus vaccines by single-radial-immunodiffusion.

  1980cites this paper
• Clinical study of a trivalent subunit influenza vaccine containing antigens of the (H1N1)-subtype.

  1980cites this paper
• Reactogenicity and immunogenicity of a surface-antigen-adsorbed influenza virus vaccine in children.

  1979cites this paper
• Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions.

  1979cites this paper
• An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines.

  1977cites this paper
• A surface antigen influenza vaccine: 2. Pyrogenicity and antigenicity

  1976cites this paper